what I liked was the 1500 prescribers.
If each prescriber has 1 new prescription written per week, that’s 6000 new patients per month at 100% refill rate.
6000 new patients at 12months of refills, generates a base level of $280mill USD revenue at $450 per bottle.
3 years to peak sales maturity the numbers become mind boggling, which is one key reason I believe they couldn’t resist raising to add resources to front end growth.
Also the 45-60day pay cycle was the other reason with sales taking another quarter to half a year to start covering expenses..
IMO
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $578.4M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.5¢ | 28.3¢ | $3.185M | 10.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 160165 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 166 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |